middle.news
How Clarity’s $226M War Chest Fuels Breakthroughs in Prostate Cancer Trials
11:12am on Friday 30th of January, 2026 AEDT
•
Healthcare
Read Story
How Clarity’s $226M War Chest Fuels Breakthroughs in Prostate Cancer Trials
11:12am on Friday 30th of January, 2026 AEDT
Key Points
Strong cash position of $226.2 million at 31 December 2025
SECuRE Phase II trial shows promising safety and efficacy in prostate cancer therapy
Co-PSMA Phase II trial achieves primary endpoint with superior lesion detection
Planned Phase III registrational trials AMPLIFY and CLARIFY progressing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CU6
OPEN ARTICLE